invoLab SA develops the intrauterine device UteroPod™, a small porous capsule and platform designed to allow IVF-derived embryos to develop within the mother’s uterus during early stages and to be retrieved later for assessment, transfer, or cryopreservation. The company combines bioengineering and microfluidic systems with reproductive medicine and is in an R&D phase building preclinical data and preparing for clinical validation.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentMedical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Intrauterine platform for in vivo development of IVF embryos prior to subsequent selection, cryopreservation or embryo transfer; with a microfluidic, porous implant and retrieval after 3–5 days.
Medical device development for reproductive medicine applications
Development of a medical intrauterine device for embryo culture, material selection, permeability, insertion and retrieval design, as well as preclinical and clinical validation.
Knowledge
No knowledge articles yet
Once invoLab SA has claimed this profile, we'll publish editorial articles and case studies here together.